4-Ethyl-5-formyl-thiophene-2-carboxylic acid → N-((S)-3-(2-Ethyl-4-[5-(4-ethyl-5-formyl-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	4-Ethyl-5-formyl-thiophene-2-carboxylic acid	HCID 20067733	—
Edukt	N-((S)-3-{2-Ethyl-4-[5-(5-formyl-3,4-dimethyl-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide	HCID 86646446	—
Produkt	N-((S)-3-(2-Ethyl-4-[5-(4-ethyl-5-formyl-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide	HCID 86646451	—

Reaktionsschritte

The title compound is prepared according to Method E starting from 4-ethyl-5-formyl-thiophene-2-carboxylic acid and N—((S)-3-{2-ethyl-4-[5-(5-formyl-3,4-dimethyl-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide; LC-MS: tR=0.73 min; [M+1]+=474.20.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US08148410B2
Quelldatensatz	uspto-grants-2012_04
ORD ID	ord-9a21bdb23fe04d12a898988bed3416fb
Quellennotiz	uspto-grants-2012_04